/images/logo.png
1.   Jia,*L. Three decades of transdisciplinary understanding and re-evaluating of the politics- and religion-involved abortion pill mifepristone and its niche in cancer metastasis chemoprevention. Cancer J. 2016.
2.   Xiaobo Yu1,*, Yusheng Lu1,*, Jingwei Shao1, Jian Liu1, Haiyan Dong1, 2, Ting Yu1, Haiyan Liang1, Qing Shi1, Lee Jia1Embedding similarities between blastocyst and cancer cells: fundamentals for abortifacients used for cancer metastatic chemoprevention 
3.   Shao#, JW., Chen#, HN., Liu, J., Zheng, GR., Li, T. Lu, Y., Xu, JG., Zheng, N., Jia*L.  Metapristone suppresses NSCLC by targeting EGFR and its PI3K/PTEN/AKT and ERK signaling pathways. Biochem Pharmacol. 
4.  Ma, J. Dong, HY., Shao, JW., Gao Y., Jia* L Global Aderegulation of ginseng products may be life-threatening to warfarin takers for preventing stroke and thromboembolism: solid evidence of serious ginseng-warfarin interaction .
5.   Jun Qian1,#, Zhou Jiang1,#, Haiyan Dong1,2#, Jingyi Yang1, Xiaobo Yu1, Jianzhong Chen1, Hongning Chen1, Qing Shi1, Lee Jia1,*The 5000-year old traditional Chinese medicineAchyranthes bidentata and our de novo conception of its metastatic chemoprevention: from phytochemistry to pharmacology .
6.   Xiufen Chen1#,Jianzhong Chen3#, Bowen Li4, Xiang Yang1, Rongjie Zeng3, Yajun Liu1, Tao Li1, Jingwei Shao1, 2*, Lee Jia1, 2*, Rodney J.Y. Ho Oral PLGA-PEG-PLGA micelles nanoparticles of US597 (an ursolic acid derivative): preparation, biological activities and pharmacokinetics. J. Pharm. Sci.
7.    Li, HN. Xu, JG., Wang ZM., Wu,# ZS., Jia,# L. Increasingly branched rolling circle amplification for the cancer gene detection. Biosensors and Bioelectronics. doi.org/10.1016/j.bios.2016.07.095,  2016.
8.   Shao, JW., Zhou, SX., Jiang Z., Chi, T., Ma, J., Guo, ML., Lee, A., Jia,*L Warfarin and coumarin-like Murraya paniculata extract down-regulate EpCAM-mediated cell adhesion: individual components versus mixture for studying botanical metastatic chemopreventives Scientific Report (accepted) 2016
9.     Lian, S., Lu., YS., Cheng YL., Yu, T., Xie, XD., Liang, HY., Jia, *L. S-nitrosocaptopril interrupts cancer cells adhesion to endothelium by suppressing cell adhesion molecules via inhibition of the NF-кB signal pathway in endothelial cells. Eur. J. Pharmacol. (accepted) IF2.53.
10.  Xiao, YY., Chen, WG., Chen, JZ., Liu, J., Shao, JW., Li, T., Zhu, YW., Ma, J. Gao, Y., Wang JC., Xu, JG., Lu, YS., Yu, SH., Jia* L. Sex-related pharmacokinetic differences and mechanisms of metapristone derived from RU486. Sci. Rep. 2016
11.    Lu, YS., Lian, Yu1, Cheng1, Liang1, Xie, JJ, Zhu, Y, Xu, H, Xie, XD, Yu, SH, Gao, Y, Jia,*L. Multifunctional nitric oxide prevents metastatic cascade spark by interrupting platelets-circulating tumor cell interplay.
12.  Sudan He; Xingtian Yang; Cuicui Yan; Suhong Yu; Zhou Jiang; Lee Jia. A Novel Coumarin from Murraya Exotica and Its Potential Prevention of Cancer Metastasis Bioorganic & Medicinal Chemistry Letters
13.  Shao, JW., Zhou, SX., Jiang Z., Chi, T., Ma, J., Guo, ML., Lee, A., Jia,*L Warfarin and coumarin-like Murraya paniculata extract down-regulate EpCAM-mediated cell adhesion: individual components versus mixture for studying botanical metastatic chemopreventives Scientific Report 2016
14.  Lian, S., Lu., YS., Cheng YL., Yu, T., Xie, XD., Liang, HY., Jia, *L. S-nitrosocaptopril interrupts cancer cells adhesion to endothelium by suppressing cell adhesion molecules via inhibition of the NF-кB signal pathway in endothelial cells. Eur. J. Pharmacol. (accepted) IF2.53.
 
15.  Xiao, YY., Chen, WG., Chen, JZ., Liu, J., Shao, JW., Li, T., Zhu, YW., Ma, J. Gao, Y., Wang JC., Xu, JG., Lu, YS., Yu, SH., Jia* L. Sex-related pharmacokinetic differences and mechanisms of metapristone derived from RU486. Sci. Rep. (under revision) 2016
16.  Lu, YS., Lian, Yu1, Cheng1, Liang1, Xie, JJ, Zhu, Y, Xu, H, Xie, XD, Yu, SH, Gao, Y, Jia,*L. Multifunctional nitric oxide prevents metastatic cascade spark by interrupting platelets-circulating tumor cell interplay.
17.  Sudan He; Xingtian Yang; Cuicui Yan; Suhong Yu; Zhou Jiang; Lee Jia. A Novel Coumarin from Murraya Exotica and Its Potential Prevention of Cancer Metastasis Bioorganic & Medicinal Chemistry Letters
18.  Shao, JW., Zhou, SX., Jiang Z., Chi, T., Ma, J., Guo, ML., Lee, A., Jia,*L Warfarin and coumarin-like Murraya paniculata extract down-regulate EpCAM-mediated cell adhesion: individual components versus mixture for studying botanical metastatic chemopreventives Scientific Report (accepted) 2016
19.  Lian, S., Lu., YS., Cheng YL., Yu, T., Xie, XD., Liang, HY., Jia, *L. S-nitrosocaptopril interrupts cancer cells adhesion to endothelium by suppressing cell adhesion molecules via inhibition of the NF-кB signal pathway in endothelial cells. Eur. J. Pharmacol. (accepted) IF2.53.
20.  Xiao, YY., Chen, WG., Chen, JZ., Liu, J., Shao, JW., Li, T., Zhu, YW., Ma, J. Gao, Y., Wang JC., Xu, JG., Lu, YS., Yu, SH., Jia* L. Sex-related pharmacokinetic differences and mechanisms of metapristone derived from RU486. Sci. Rep. (under revision) 2016
21,  Lu, YS., Lian, Yu1, Cheng1, Liang1, Xie, JJ, Zhu, Y, Xu, H, Xie, XD, Yu, SH, Gao, Y, Jia,*L. Multifunctional nitric oxide prevents metastatic cascade spark by interrupting platelets-circulating tumor cell interplay.
22.  Sudan He; Xingtian Yang; Cuicui Yan; Suhong Yu; Zhou Jiang; Lee Jia. A Novel Coumarin from Murraya Exotica and Its Potential Prevention of Cancer Metastasis Bioorganic & Medicinal Chemistry Letters 
                                                            (submitted for peer review)
1. Yu S, Yan C, Yang X, He S, Liu J, Qin C, et al. Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention. Scientific Reports. 2016;6.
2. Xu J, Wu ZS, Wang Z, Li H, Le J, Jia L. Two-wheel drive-based DNA nanomachine and its sensing potential for highly sensitive analysis of cancer-related gene. Biomaterials. 2016;100:110–7.
3. Xu J, Wu ZS, Li H, Wang Z, Le J, Zheng T, et al. Dual-cyclical nucleic acid strand-displacement polymerization based signal amplification system for highly sensitive determination of p53 gene. Biosensors & Bioelectronics. 2016.
4. Xu J, Li H, Wu ZS, Qian J, Xue C, Jia L. Double-stem Hairpin Probe and Ultrasensitive Colorimetric Detection of Cancer-related Nucleic Acids. Theranostics. 2016;6(3):318-27.
5. Xiao Y, Zhu Y, Yu S, Yan C, Ho RJY, Jian L, et al. Thirty-day rat toxicity study reveals reversible liver toxicity of mifepristone (RU486) and metapristone. Toxicology Mechanisms & Methods. 2016:1-10.
6. Xiao Y, Zhu Y, Chen J, Li T, Jia L. Bioavailability and pharmacokinetics of nanometer drug metapristone in different genders, a new cancer metastasis chemopreventive agent derived from mifepristone (RU486). Nanomedicine Nanotechnology Biology & Medicine. 2016;12(2):484-.
7. Wang J, Chen J, Zhu Y, Zheng N, Liu J, Xiao Y, et al. In vitro and in vivo efficacy and safety evaluation of metapristone and mifepristone as cancer metastatic chemopreventive agents. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie. 2016;78:291-300.
8. Jiang Z, Pang Y, Yu X, Zhou S, Qian J, Zheng N, et al. The paradigm-shifting idea and its practice: from traditional abortion Chinese medicine Murray paniculata to safe and effective cancer metastatic chemopreventives. Oncotarget. 2016.
9. Gao Y, Gu S, Zhang Y, Xie X, Yu T, Lu Y, et al. The Architecture and Function of Monoclonal Antibody‐Functionalized Mesoporous Silica Nanoparticles Loaded with Mifepristone: Repurposing Abortifacient for Cancer Metastatic Chemoprevention. 2016;12(19):2595-608.
10. Dong HY, Wang J, Zhang T, Ji MA, Han LY, Xiao-Huang TU, et al. Aptamers and their biological applications in bio-medicine and analytical diagnostics. Chinese Journal of Pharmaceutical Analysis. 2016.
11. Dong H, Ji M, Jie W, Wu ZS, Sinko PJ, Jia L. A Biofunctional Molecular Beacon for Detecting Single Base Mutations in Cancer Cells. Molecular therapy Nucleic acids. 2016;5.
12. Dong H, Gao Y, Sinko PJ, Wu Z, Xu J, Jia L. The nanotechnology race between China and the United States. Nano Today. 2016;11:7–12.
13. Zhou J, Yang J, Pang Y, Yang X, Yu S, Jia L. Bioactivity-guided fast screen and identification of cancer metastasis chemopreventive components from raw extracts of Murraya exotica. Journal of Pharmaceutical & Biomedical Analysis. 2015;107C(3):341-5.
14. Yusheng Lu BS, Haiyan Liang BS, Ting Yu BS, Jingjing Xie BS, Mmed SC, Haiyan Dong MS, et al. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry. Cancer. 2015;121(17):3036–45.
15. Yu S, Yang X, Zhu Y, Xie F, Lu Y, Yu T, et al. Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex. Scientific Reports. 2015;5:7830-.
16. Yu G, Li Z, Xie X, Wang C, You J, Fan M, et al. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation. European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences. 2015;70:55–63.
17. Yu G, Jin B, Shen W, Sinko P, Xie X, Zhang H, et al. China and the United States—Global partners, competitors and collaborators in nanotechnology development. Nanomedicine Nanotechnology Biology & Medicine. 2015;12(1):13–9.
18. Xu J, Wu ZS, Shen W, Xu H, Li H, Jia L. Cascade DNA nanomachine and exponential amplification biosensing. Biosensors & Bioelectronics. 2015;73:19-25.
19. Xu J, Qian J, Li H, Wu ZS, Shen W, Jia L. Intelligent DNA machine for the ultrasensitive colorimetric detection of nucleic acids. Biosensors & Bioelectronics. 2015;75:41-7.
20. Xu J, Dong H, Shen W, He S, Li H, Lu Y, et al. New molecular beacon for p53 gene point mutation and significant potential in serving as the polymerization primer. Biosensors & Bioelectronics. 2015;66:504-11.
21. Xie X, Li F, Zhang H, Lu Y, Lian S, Lin H, et al. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences. 2015;83:28-35.
22. Xie J, Yu G, Zhao R, Sinko PJ, Gu S, Wang J, et al. Ex vivo and in vivo capture and deactivation of circulating tumor cells by dual-antibody-coated nanomaterials. Journal of Controlled Release. 2015;209:159-69.
23. Xie J, Wang J, Chen H, Shen W, Sinko PJ, Dong H, et al. Multivalent conjugation of antibody to dendrimers for the enhanced capture and regulation on colon cancer cells. Scientific Reports. 2015;5.
24. Xie J, Lu Y, Dong H, Zhao R, Chen H, Shen W, et al. Enhanced Specificity in Capturing and Restraining Circulating Tumor Cells with Dual Antibody–Dendrimer Conjugates. Advanced Functional Materials. 2015;25(8):1304–13.
25. Xie J, Dong H, Chen H, Zhao R, Sinko PJ, Shen W, et al. Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial. Journal of Nanobiotechnology. 2015;13(1):1-13.
26. Xiang L, Chi T, Tang Q, Yang X, Ou M, Chen X, et al. A pentacyclic triterpene natural product, ursolic acid and its prodrug US597 inhibit targets within cell adhesion pathway and prevent cancer metastasis. Oncotarget. 2015;6(11):9295-312.
27. Wan L, Dong H, Xu H, Ma J, Zhu Y, Lu Y, et al. Aspirin, lysine, mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis: prevent seeds from gemmating on soil. Oncotarget. 2015;6(34):35157-72.
28. Li Y, Zeng RJ, Chen JZ, Wu YB, Chou GX, Gao Y, et al. Pharmacokinetics and metabolism study of isoboldine, a major bioactive component from Radix Linderae in male rats by UPLC–MS/MS. Journal of Ethnopharmacology. 2015;171:154-60.
29. Kim JW, Lee SA, Go DS, Park BS, Kim SG, Yu SK, et al. Apoptotic Activity of Curcumin and EF-24 in HTB-41 Human Salivary Gland Epidermoid Carcinoma Cells. Revista De Educación De La Universidad De Granada. 2015;40(2):63-9.
30. Dong H, Wu ZS, Xu J, Ji M, Zhang H, Jie W, et al. Novel multifunction-integrated molecular beacon for the amplification detection of DNA hybridization based on primer/template-free isothermal polymerization. Biosensors & Bioelectronics. 2015;72:182-90.
31. † R-JZ, † YL, Chen JZ, Chou GX, Gao Y, Shao JW, et al. A novel UPLC-MS/MS method for sensitive quantitation of boldine in plasma, a potential anti-inflammatory agent: application to a pharmacokinetic study in rats. Biomedical Chromatography. 2015;29(3):459-64.
32. Zhou J, Shao J, Yang T, Jian W, Jia L. Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy. Journal of Pharmaceutical & Biomedical Analysis. 2014;87(10):98-104.
33. Yu G, Xie J, Chen H, Gu S, Zhao R, Shao J, et al. Nanotechnology-based intelligent drug design for cancer metastasis treatment. Biotechnology Advances. 2014;32(4):761-77.
34. Xie J, Zhao R, Gu S, Dong H, Wang J, Lu Y, et al. The architecture and biological function of dual antibody-coated dendrimers: enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention. Theranostics. 2014;4(12):1250-63.
35. Xie J, Zhao R, Chen H, Xie X, Jia L. Specificity of Capturing and Restraining Colon Cancer Cells by Multifunctional Nanomaterial Conjugates. Science & Technology Review. 2014;32(34):26-32.
36. Wang J, Jiang Z, Xiang L, Li Y, Ou M, Yang X, et al. Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis. Scientific Reports. 2014;4.
37. Wang J, Chen J, Wan L, Shao J, Lu Y, Zhu Y, et al. Synthesis, Spectral Characterization, and In Vitro Cellular Activities of Metapristone, a Potential Cancer Metastatic Chemopreventive Agent Derived from Mifepristone (RU486). Aaps Journal. 2014;16(2):289-98.
38. Lu Y, Yu T, Liang H, Wang J, Xie J, Shao J, et al. Nitric Oxide Inhibits Hetero-adhesion of Cancer Cells to Endothelial Cells: Restraining Circulating Tumor Cells from Initiating Metastatic Cascade. Scientific Reports. 2014;4(10):4344.
39. Gao Y, Shao J, Jiang Z, Chen J, Gu S, Yu S, et al. Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics. Drug Discovery Today. 2014;19(3):326-40.
40. Chen P, Zhang X, Jia L, Prud'Homme RK, Szekely Z, Sinko PJ. Optimal structural design of mannosylated nanocarriers for macrophage targeting. Journal of Controlled Release. 2014;194:341-9.
41. Chen JZ, Wang JC, Gao Y, Zeng RJ, Jiang Z, Zhu YW, et al. A novel UPLC/MS/MS method for rapid determination of metapristone in rat plasma, a new cancer metastasis chemopreventive agent derived from mifepristone (RU486) ☆. Journal of Pharmaceutical & Biomedical Analysis. 2014;95(3):158-63.
42. † JC, † JW, Shao J, Gao Y, Xu J, Yu S, et al. The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis. Medicinal Research Reviews. 2014;34(5):979–1000.
43. Yin JJ, Sharma S, Shumyak SP, Wang ZX, Zhou ZW, Zhang Y, et al. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment. Plos One. 2013;8(5):e62289.
44. Xie J, Shao J, Lu Y, Chen J, Wang J, Yu S, et al. Separation of Ginseng Active Ingredients and their Roles in Cancer Metastasis Supplementary Therapy. Current Drug Metabolism. 2013;14(5):616-23.
45. Shao J, Jia L. Potential serious interactions between nutraceutical ginseng and warfarin in patients with ischemic stroke. Trends in Pharmacological Sciences. 2013;34(2):85–6.
46. Shao J, Dai Y, Zhao W, Xie J, Xue J, Ye J, et al. Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells. Cancer Letters. 2013;330(1):49–56.
47. Jiang Z, Shao J, Chen M, Wang J, Jia L. A novel SPE-HPLC method for simultaneous determination of selected sulfonated phthalocyanine zinc complexes in mouse plasma following cassette dosing. Analyst. 2013;138(15):4385-92.
48. Analysis NP. Nanoscaled Proteomic Analysis. 2013:65-81.
49. Zhang F, Xue J, Shao J, Li J. Compilation of 222 drugs’ plasma protein binding data and guidance for study designs. Drug Discovery Today. 2012;17(9–10):475-85.
50. Xue X, You S, Zhang Q, Wu Y, Zou GZ, Wang PC, et al. Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction. Molecular Pharmaceutics. 2012;9(3):634-44.
51. Shao J, Xue J, Dai Y, Hong L, Chen N, Li J, et al. Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser PHOTOCYANINE: ROS production, apoptosis, cell cycle arrest. European Journal of Cancer. 2012;48(13):2086-96.
52. Rayburn E, Wang W, Li M, Zhang X, Xu H, Li H, et al. Preclinical pharmacology of novel indolecarboxamide ML-970, an investigative anticancer agent. Cancer Chemotherapy & Pharmacology. 2012;69(69):1423-31.
53. Meng J, Yang XD, Jia L, Liang XJ, Wang C. Impacts of nanoparticles on cardiovascular diseases: modulating metabolism and function of endothelial cells. Current Drug Metabolism. 2012;13(8):1123-9.
54. Jia X, Jia L. Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy. Current Drug Metabolism. 2012;13(8):1119-22.
55. Jia L. Science Requires Coexisting of Opposite Opinions:“One Country, Two Systems”. Pharmaceutical Regulatory Affairs Open Access. 2012;01(4).
56. Zhe XU, Jia L. Current evaluation of ginseng in etymology,pharmacognosy,products,and market. Drugs & Clinic. 2011.
57. Reid JM, Buhrow SA, Kuffel MJ, Jia L, Spanswick VJ, Hartley JA, et al. Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats. Cancer Chemotherapy & Pharmacology. 2011;68(3):777-86.
58. Meng J, Xing J, Wang Y, Lu J, Zhao Y, Gao X, et al. Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis. Nanoscale. 2011;3(11):4713-9.
59. Kummar S, Chen A, Ji J, Zhang Y, Reid JM, Ames M, et al. Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas. Cancer Research. 2011;71(17):5626-34.
60. Jing XU, Jia L. Constituents of ginseng and quality evaluation of ginseng products. Drug Evaluation Research. 2011.
61. Jia L, Zhao Y, Liang XJ. Fast evolving nanotechnology and relevant programs and entities in China. Nano Today. 2011;6(6):6-11.
62. Jia L, Qian K. An Evidence-based Perspective of Panax Ginseng (Asian Ginseng) and Panax Quinquefolius (American Ginseng) as a Preventing or Supplementary Therapy for Cancer Patients2011. 85-96 p.
63. Jia L, Gorman GS, Coward LU, Noker PE, Mccormick D, Horn TL, et al. Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. Cancer Chemotherapy & Pharmacology. 2011;68(2):513-24.
                          
 
© 2018-2020 版权所有 闽江学院海洋研究院海洋药物研发中心 地址:福建省福州市闽侯县上街镇溪源宫路200号 访问量: